We have previously reported that genetically engineered Ccl2-/-/Cx3cr1-/- mice on rd8 background (Ccl2-/-/Cx3cr1-/-) developed a broad spectrum of AMD-like pathology with early onset and high penetrance [3-5]. The gene discussed is CCL2; the disease is age-related macular degeneration.